X-group (possible homology)

2004 P-loop domains-like

Ligands and drugs

110,464
Member domains
18,883
with ligand contacts (≤ 4 Å)
17.1% of members
18,103
with DrugDomain annotations
16.4% of members
15,996
with a DrugBank compound
14.5% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

1,742
Proteins with classified ligands
16
Superclasses bound (of 23)
7.5
Superclasses per 20 proteins
narrower than 53% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Mixed metal/non-metal compounds18836.15.21×q < 0.0001
Nucleosides, nucleotides, and analogues1,576474.83.32×q < 0.0001
Homogeneous metal compounds1,263843.11.50×q < 0.0001
Organosulfur compounds2635.30.74×q = 0.17
Homogeneous non-metal compounds224369.70.61×q < 0.0001
Alkaloids and derivatives35.90.51×q = 0.37
Benzenoids56125.60.45×q < 0.0001
Organic nitrogen compounds2254.80.40×q < 0.0001
Phenylpropanoids and polyketides1435.70.39×q = 1.4e-4
Organic oxygen compounds109342.00.32×q < 0.0001
Organic acids and derivatives83265.80.31×q < 0.0001
Lipids and lipid-like molecules55191.20.29×q < 0.0001
Organoheterocyclic compounds72264.30.27×q < 0.0001
Hydrocarbons212.00.17×q = 2.3e-3
Organohalogen compounds34.90.61×not tested
Organometallic compounds12.50.41×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB16833ADPAdenosine disphosphate4,725
DB00171ATPATP3,189
DB04315GDPGuanosine-5'-Diphosphate1,827
DB02930AGSAdenosine 5'-[gamma-thio]triphosphate1,210
DB02082GNPPhosphoaminophosphonic acid guanylate ester935
DB04137GTPGuanosine-5'-Triphosphate699
DB04444ALFTetrafluoroaluminate Ion281
DB03725GCP5'-Guanylylmethylenebisphosphonate241
DB01812A3PAdenosine 3',5'-diphosphate161
DB01864GSP5'-Guanosine-Diphosphate-Monothiophosphate156
DB04005UTPUridine 5'-triphosphate135
DB02431CTPCytidine-5'-Triphosphate127
DB00131AMPAdenosine phosphate122
DB01717AP5Bis(Adenosine)-5'-Pentaphosphate116
DB02452TTPThymidine 5'-triphosphate111
DB03429CDLTetrastearoyl cardiolipin95
DB03435UDPUridine-5'-Diphosphate90
DB03222DTPdATP83
DB019725GPGuanosine-5'-Monophosphate71
DB03909ACPAdenosine-5'-[Beta, Gamma-Methylene]Triphosphate71

Most frequently bound compounds

PDB ligandNameDomains in contact
MGmetalMAGNESIUM ION9,035
ADPADENOSINE-5'-DIPHOSPHATE5,001
ATPADENOSINE-5'-TRIPHOSPHATE3,354
GDPGUANOSINE-5'-DIPHOSPHATE1,831
AGSPHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER1,453
ANPPHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER1,063
GNPPHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER930
GTPGUANOSINE-5'-TRIPHOSPHATE667
CLCHLORIDE ION585
CAmetalCALCIUM ION461
BEFBERYLLIUM TRIFLUORIDE ION454
ZNmetalZINC ION375
NAmetalSODIUM ION322
ALFTETRAFLUOROALUMINATE ION315
MNmetalMANGANESE (II) ION257
SF4IRON/SULFUR CLUSTER246
GCPPHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER240
A3PADENOSINE-3'-5'-DIPHOSPHATE168
GSP5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE156
AF3ALUMINUM FLUORIDE141